Paul E Gormisky

Title: Paul E Gormisky: Innovator in Heterocyclic PAD4 Inhibitors

Introduction

Paul E Gormisky is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit the PAD4 enzyme. His work is crucial for advancing treatments for diseases associated with PAD4 enzyme activity.

Latest Patents

Gormisky holds a patent for "Heterocyclic PAD4 inhibitors." This patent describes substituted heterocyclic compounds of Formula (Ia), which serve as inhibitors of PAD4. The disclosure includes methods for preparing these compounds, pharmaceutical compositions that comprise them, and their use in treating diseases linked to PAD4 enzyme activity. He has 1 patent to his name.

Career Highlights

Throughout his career, Gormisky has been associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has focused on innovative solutions in drug development, particularly in the area of enzyme inhibitors.

Collaborations

Gormisky has collaborated with esteemed colleagues such as Kumaravel Selvakumar and Venkatram Reddy Paidi. These partnerships have enhanced the research and development efforts in their respective fields.

Conclusion

Paul E Gormisky's contributions to the field of pharmaceutical chemistry, particularly through his patent on PAD4 inhibitors, highlight his role as an innovator. His work continues to impact the development of treatments for diseases associated with PAD4 enzyme activity.